Sort by
Refine Your Search
-
genomic variation and phenotypic traits, predict gene essentiality, and model evolutionary trajectories. The role involves using large language models as coding assistants for efficient pipeline development
-
on a fixed term contract until 28 February 2029. If you are still awaiting your PhD to be awarded you will be appointed at Grade 6, spine point 30. Upon written confirmation that you have been awarded
-
of translating discovery science into therapeutic applications for cancer patients by enabling effective collaborations between scientists and clinicians to improve cancer detection and treatment. A primary focus
-
healthcare easy or difficult for them and how local cancer services can support them better. Through the workshops, we will aim to find a solution to some of the barriers that they may face. This is a
-
environment, and benefit from diverse project team skill and expertise. The successful candidate should have a PhD in cartilage, stem cell or protease biology (or a related discipline). Expertise in mammalian
-
new stable co-electrocatalysts using high-throughput synthesis and screening and evaluate them for activity and selectivity towards methane or syngas. You will have a PhD in chemistry or chemical
-
opportunities with national and international partners. We are looking for a candidate who holds (or will soon hold) a PhD in Chemistry (or related areas in materials science and physical chemistry) whose main
-
activities, and will be supported to develop their own independent research trajectories and career pathways throughout the project with access to bespoke training and conference budgets. You should have a PhD
-
the evolutionary, physiological and clinical consequences and drivers of this paradoxical behaviour You should have a PhD in a relevant discipline and an eagerness and ability to undertake interdisciplinary
-
should have a PhD degree in Biochemistry, Biomedical Science, Biological Sciences, Omics science, Microbiology or a related discipline and experience of applying mass spectrometry in human signalling